IDEX Corporation reported its third‑quarter 2025 financial results, showing net sales of $878.7 million, up 10% year‑over‑year, and net income of $127.8 million.
Adjusted earnings per share were $2.03, surpassing the consensus estimate of $1.93; adjusted EBITDA reached $239.8 million, giving a margin of 27.3%; operating cash flow was $203.5 million and free cash flow stood at $188.7 million.
Segment performance highlighted the Health & Science Technologies (HST) unit, which generated $381.0 million in sales and $105.4 million in adjusted EBITDA, a margin of 27.7%; the Fluid & Metering Technologies (FMT) segment posted $317.1 million in sales and $106.8 million in adjusted EBITDA, a 33.7% margin; Fire & Safety/Diversified Products (FSDP) reported $181.9 million in sales and $49.3 million in adjusted EBITDA, a 27.1% margin. HST sales grew 22% year‑over‑year, driven in part by the acquisition of Mott Corporation completed in September 2024.
IDEX projected fourth‑quarter revenue of $871.5 million, below the analyst estimate of $889.7 million, and reiterated its full‑year adjusted earnings per share guidance of $7.86‑$7.91. The guidance miss is attributed to slower demand in industrial markets and higher raw‑material costs.
During the quarter, the company repurchased $75 million of shares, part of a $1 billion share‑repurchase authorization.
The results reflect ongoing macroeconomic headwinds, including inflationary pressure and supply‑chain constraints, but also highlight strong demand in data‑center and life‑science markets, underscoring IDEX’s ability to generate robust earnings while navigating headwinds.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.